Global Biopharmaceutical Fermentation Systems Market Opportunities 2024, Forecast To 2033
11 Jul, 2024
The biopharmaceutical fermentation systems market has also shown robust growth, increasing from $22.57 billion in 2023 to $24.82 billion in 2024, reflecting a CAGR of 9.9%. This growth in the historic period is driven by increasing demand for biologics, supportive regulatory frameworks, industry consolidation, growing investments in research and development, and advancements in the healthcare landscape. Looking ahead, the market is projected to grow to $36.55 billion by 2028, maintaining a CAGR of 10.2%. Anticipated trends include the adoption of continuous manufacturing processes, expansion in personalized medicine applications, growth in the biosimilars market, advancements in analytics and AI, and a focus on sustainability and environmental impact.
Major Driver In The Biopharmaceutical Fermentation Systems Market
The growing biologics pipeline fuels expansion in the biopharmaceutical fermentation systems market. Biologics, derived from living organisms, include vaccines and therapeutic proteins, driven by biotechnological advances and personalized therapy demands. Biopharmaceutical fermentation systems support large-scale production of these therapies. In 2023, FDA approvals for new drugs increased by 50% compared to 2022, underscoring the market's growth trajectory. Therefore, the expanding biologics pipeline drives the biopharmaceutical fermentation systems market, projected to grow steadily from 2023 to 2028.
Request A Free Sample Of The Global Biopharmaceutical Fermentation Systems Market ReportGlobal Biopharmaceutical Fermentation Systems Market Segmentation
The biopharmaceutical fermentation systems market covered in this report is segmented –
1) By Product: Upstream Products, Downstream Products
2) By Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics, Other Applications
3) By End-User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, Food Industry, Other End-Users
By Geography:The regions covered in the biopharmaceutical fermentation systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the biopharmaceutical fermentation systems market in 2023.
The Biopharmaceutical Fermentation Systems Global Market Report 2024 furnishes information about the global biopharmaceutical fermentation systems market, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.
Biopharmaceutical Fermentation Systems Market Competitive Landscape
F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., 3M Company, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE Healthcare, Agilent Technologies Inc., Lonza Group AG, GEA Group AG, Sartorius Stedim Biotech, Bio-Rad Laboratories Inc., Pall Corporation, Nova Biomedical, Eppendorf AG, Repligen Corporation, ZETA Holding GmbH, New Brunswick Scientific, ABEC Inc., Pierre Guérin Technologies, AntoXa Corporation, Applikon Biotechnology, Cellexus Ltd., Infors HT, BioPharm Process Associates LLC
Purchase The Global Biopharmaceutical Fermentation Systems Market Report Directly And Get A Swift DeliveryBiopharmaceutical Fermentation Systems Market Overview
A biopharmaceutical fermentation system cultivates microorganisms or cells under controlled conditions to produce biopharmaceutical products like proteins, antibodies, and vaccines.
Biopharmaceutical Fermentation Systems Global Market Report 2023 provides data on the global biopharmaceutical fermentation systems market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The biopharmaceutical fermentation systems market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.